Platelet Rich Plasma (PRP) Bio Stimulant Gel Dressing in Treating Chronic Non Healing Leg and Foot Ulcers: Cost and Effectiveness
1 other identifier
interventional
44
1 country
1
Brief Summary
Background Chronic non-healing ulcer is a common problem met in clinical practice and represents a burden to the patients. Chronic ulcer lacks growth factors (GFs) to promote the healing process and is frequently followed by superadded infections. Ordinary technique such as wound debridement and regular dressings cannot provide adequate results as these techniques cannot provide the necessary GFs. Platelet-rich plasma (PRP) helps wound healing by releasing various types of GFs. The aim: to evaluate and compare the efficacy of PRP dressing versus traditional dressings in the treatment of chronic non-healing leg and foot ulcers of different etiology as regard cost of overall treatment and effectiveness (reduction of the size of the ulcer and safety of the technique). Methods This prospective study was performed on inpatients and outpatients in general surgery department, Zagazig university hospital from June 2017 to January 2019. Patients were divided randomly into two groups: group A received PRP dressing (N=22, 50%) and group B received conventional ordinary dressing (N=22, 50%).The mean follow-up period was 3 months after the last dressing. Patients treated with PRP at once-weekly interval for a maximum of 12 dressings while patients with ordinary dressings may need one dressing every other day for a maximum of 12 weeks. The reduction in the size of the ulcers (area and volume) in both groups was assessed using centimeter scale and Digital photographs before and after each session and during follow up period. Keywords: Platelet-rich plasma, ulcers, non-healing, ordinary dressing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 12, 2019
CompletedFirst Posted
Study publicly available on registry
August 22, 2019
CompletedAugust 22, 2019
August 1, 2019
1.6 years
August 12, 2019
August 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change the ulcer size
healing of the ulcer is assessed using centimeter scale before each dressing
1.8 years
Study Arms (2)
PRP dressing
EXPERIMENTALconventional ordinary dressing
EXPERIMENTALInterventions
conventional ordinary dressing for treatment of chronic ulcer
Eligibility Criteria
You may qualify if:
- years old,
- males and non-pregnant females,
- hemoglobin (\> 10 gm. /dL),
- post-prandial blood sugar ≤ 140 mg% if diabetic,
- Wounds free of infection (sterile swab) or necrosis.
You may not qualify if:
- malignant ulcer(by biopsy),
- pus discharge/slough,
- ulcer with exposed tendons/ligaments/bone,
- ischemic ulcer (by duplex U/S),
- non-compliant patients ,
- radiation near to the site of ulcer,
- osteomyelitis of underlying bone (x-ray-bone scan) ,
- steroids therapy ,
- thrombocytopenia(\< 150,000/dl)
- patients unfit or refuse blood donation from himself or from others.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tamer Alsaied Alnaimy
Zagazig, Sharqia Province, 055, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
tamer A Alnaimy, MD
faculty of medicine Zagazig university
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical professour
Study Record Dates
First Submitted
August 12, 2019
First Posted
August 22, 2019
Study Start
June 1, 2017
Primary Completion
January 1, 2019
Study Completion
April 1, 2019
Last Updated
August 22, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share